Innovation

Chris Kirchner was arrested in 2023 following a Forbes investigation that revealed he overstated company financials and spent lavishly on personal expenses.

A class of diabetes and weight loss drugs that includes Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro could also help protect against a variety of cancers, according to new research published Friday, adding to mounting evidence that injections offer numerous additional health benefits as pressure builds for insurers and public health providers to cover the popular medication in spite of persistent shortages and cost concerns.

Amazon claims that all electricity it consumed in 2023 was “matched” with 100% renewable energy. Experts criticise the report’s vagueness.

Microsoft has invested $13 billion in OpenAI, but said in a letter it felt confident over the ChatGPT maker’s future and no longer believed an observer seat on the startup’s board was necessary.

The AI boom undoubtedly resembles the dot-com bubble but with a difference. Back then, most startups carried the risks, while now, giant AI pioneers are unlikely to go broke. Rather, investors will suffer.

Data61 – the data and digital arm of Australia’s national science agency CSIRO – had four scientists nominated for APAC Women in AI awards. These two took home top prizes.

The South Korean tech giant said it expects to rake in second quarter profits more than 15 times the size than it did the same time last year.

The acquisition at a time when Boeing faces major turmoil over safety issues plaguing its aircraft and potential federal criminal charges in the U.S.

The enviro-tech innovator’s patented enzymatic recycling technology allows industries to create an infinite life for plastics.

Anthropic’s Claude 3.5 Sonnet can compete with the best AI models out there and the company contrasts itself to rivals like OpenAI by pitching itself as a safety-first AI firm.